-
1
-
-
0037029424
-
Multiple sclerosis
-
Compston A, Coles AJ. Multiple sclerosis. Lancet. 2002 ; 359: 1221-31
-
(2002)
Lancet
, vol.359
, pp. 1221-1231
-
-
Compston, A.1
Coles, A.J.2
-
2
-
-
79955585784
-
Challenges to clinical trials in multiple sclerosis: Outcome measures in the era of disease-modifying drugs
-
Hyland M, Rudick RA. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs. Current Opinion in Neurology. 2011 ; 24: 255-261
-
(2011)
Current Opinion in Neurology
, vol.24
, pp. 255-261
-
-
Hyland, M.1
Rudick, R.A.2
-
3
-
-
77950906842
-
Imaging biomarkers in multiple sclerosis
-
Filippi M, Agosta F. Imaging biomarkers in multiple sclerosis. J Magn Reson Imaging. 2010 ; 31: 770-788
-
(2010)
J Magn Reson Imaging
, vol.31
, pp. 770-788
-
-
Filippi, M.1
Agosta, F.2
-
4
-
-
62349108495
-
MRI as an outcome in multiple sclerosis clinical trials
-
Daumer M, Neuhaus A, Morrissey S, et al. MRI as an outcome in multiple sclerosis clinical trials. Neurology. 2009 ; 72: 705-711
-
(2009)
Neurology
, vol.72
, pp. 705-711
-
-
Daumer, M.1
Neuhaus, A.2
Morrissey, S.3
-
5
-
-
77950375277
-
Improved detection of active multiple sclerosis lesions: 3D subtraction imaging
-
Moraal B, Wattjes MP, Geurts JJ, et al. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology. 2010 ; 255: 154-163
-
(2010)
Radiology
, vol.255
, pp. 154-163
-
-
Moraal, B.1
Wattjes, M.P.2
Geurts, J.J.3
-
6
-
-
0029311748
-
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: Design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)
-
Jacobs LD, Cookfair DL, Rudick RA, et al. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating- remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). Mult Scler. 1995 ; 1: 118-135
-
(1995)
Mult Scler
, vol.1
, pp. 118-135
-
-
Jacobs, L.D.1
Cookfair, D.L.2
Rudick, R.A.3
-
7
-
-
0030692770
-
The measurement of ambulatory impairment in multiple sclerosis
-
Schwid SR, Goodman AD, Mattson DH, et al. The measurement of ambulatory impairment in multiple sclerosis. Neurology. 1997 ; 49: 1419-1424
-
(1997)
Neurology
, vol.49
, pp. 1419-1424
-
-
Schwid, S.R.1
Goodman, A.D.2
Mattson, D.H.3
-
8
-
-
67649472442
-
Cerebrospinal fluid biomarkers in multiple sclerosis
-
Tumani H, Hartung HP, Hemmer B, et al. Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis. 2009 ; 35 (2). 117-127
-
(2009)
Neurobiol Dis
, vol.35
, Issue.2
, pp. 117-127
-
-
Tumani, H.1
Hartung, H.P.2
Hemmer, B.3
-
9
-
-
0034633665
-
Assessment: Prevention of postlumbar puncture headaches: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Evans RW, Armon C, Frohman EM, et al. Assessment: prevention of postlumbar puncture headaches: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2000 ; 55: 909-914
-
(2000)
Neurology
, vol.55
, pp. 909-914
-
-
Evans, R.W.1
Armon, C.2
Frohman, E.M.3
-
11
-
-
0035956557
-
Atraumatic Sprotte needle reduces the incidence of post-lumbar puncture headaches
-
Strupp M, Schueler O, Straube A, et al. Atraumatic Sprotte needle reduces the incidence of post-lumbar puncture headaches. Neurology. 2001 ; 57: 2310-2312
-
(2001)
Neurology
, vol.57
, pp. 2310-2312
-
-
Strupp, M.1
Schueler, O.2
Straube, A.3
-
12
-
-
33644982566
-
Safety and acceptability of the research lumbar puncture
-
Peskind ER, Riekse R, Quinn JF, et al. Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord. 2005 ; 19 (4). 220-225
-
(2005)
Alzheimer Dis Assoc Disord
, vol.19
, Issue.4
, pp. 220-225
-
-
Peskind, E.R.1
Riekse, R.2
Quinn, J.F.3
|